What to Watch for Amid Biotech’s Resurgence
It’s been a slog for biotech stocks in 2024, but things are turning bullish again. Here are the trends to ...
by Matthew Clark | Nov 13, 2024 | Money & Markets Daily
It’s been a slog for biotech stocks in 2024, but things are turning bullish again. Here are the trends to ...
by Adam O'Dell | Nov 5, 2024 | Money & Markets Daily
The biotech sector has had an up and down year, but there are signs of a turnaround. Here's how Green ...
by Adam O'Dell | Mar 26, 2024 | Money & Markets Daily
In 2023, Tesla stock was riding high — leading the market as a member of the “Magnificent Seven.” But there's ...
by Matthew Clark | Mar 18, 2024 | Money & Markets Daily
After a rough bear market, it looks like biotech stocks are charging higher. Here's a trend that points to more ...
by Michael Carr | Nov 29, 2023 | Money & Markets Daily
Trends in health care can become powerful tailwinds. Genomics is a good example of this. Here's how to find the ...
by Adam O'Dell | Oct 25, 2023 | Money & Markets Daily
For investors, seasonal patterns can be an extremely powerful tool. Here's how these trends have played out in the biotech ...
by Matthew Clark | Sep 4, 2023 | Money & Markets Daily
Novo Nordisk (NYSE: NVO) stock is rallying thanks to Ozempic, a diabetes drug that many are using for weight loss. ...
by Adam O'Dell | Jul 8, 2022 | Investing
Cathie Wood is one of the greatest investors of our time. Here's why we aren't worried her ARK Innovation ETF ...
by Adam O'Dell | Feb 21, 2022 | Investing
Do you want to be a biotech value investor? It's possible to target solid companies trading at cheaper valuations in ...
by Matthew Clark | Oct 23, 2021 | Markets, Podcast
Biotech is one of the fastest-growing markets today. ETFs are a great way for investors to get started in this ...
In his free newsletter, What My System Says Today, Adam O’Dell uses his Green Zone Power Rating system to keep you in the know and focused on the market’s best (and worst) opportunities. It’s a data-driven approach underpinned by Wall Street-caliber tools you can only get here at Money & Markets. Sign up for FREE access to our daily emails now!
Enter your username and password below